0001493152-23-013314.txt : 20230424 0001493152-23-013314.hdr.sgml : 20230424 20230424061512 ACCESSION NUMBER: 0001493152-23-013314 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230421 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230424 DATE AS OF CHANGE: 20230424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 23837871 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 8-K 1 form8-k.htm
0001460702 false 0001460702 2023-04-21 2023-04-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 21, 2023

 

Qualigen Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37428   26-3474527

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

2042 Corte Del Nogal, Carlsbad, California 92011

(Address of principal executive offices) (Zip Code)

 

(760) 918-9165

(Registrant’s telephone number, including area code)

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, par value $.001 per share   QLGN   The Nasdaq Capital Market of The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On April 20, 2023, Qualigen Therapeutics, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”), the Company is no longer in compliance with the timely filing requirements for continued listing under Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”).

 

The Notice states that, under Nasdaq rules, the Company has 60 calendar days to submit to Nasdaq a plan (the “Plan”) to regain compliance with Nasdaq’s continued listing requirements (the “Plan Deadline”). If the Plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to regain compliance. The Company can also regain compliance with Nasdaq’s continued listing requirements at any time prior to the Plan Deadline by filing the Form 10-K, along with any subsequent periodic reports that may become due, and by continuing to comply with Nasdaq’s other continued listing requirements. The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

 

The Company intends to file the Form 10-K as soon as practicable and prior to the Plan Deadline; however, no assurance can be given as to the definitive date on which the Form 10-K will be filed.

 

On April 21, 2023, the Company issued a press release regarding the notice received from Nasdaq. A copy of the press release is attached hereto as Exhibit 99.1.

 

Forward Looking Statements

 

This report contains forward-looking statements. Any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding the expected timing for the filing of the Form 10-K and the Company’s ability to regain compliance with Nasdaq’s requirements for continued listing. These statements are subject to risks and uncertainties, and actual results may differ materially from these statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

No.

   Description
     
99.1   Press Release dated April 21, 2023 issued by Qualigen Therapeutics, Inc.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  QUALIGEN THERAPEUTICS, INC.
     
Date: April 24, 2023 By: /s/ Michael S. Poirier
    Michael S. Poirier, Chief Executive Officer

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

 

CARLSBAD, Calif., April 21, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today reports that on April 20, 2023, it received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”) as required under Section 5250(c) of Nasdaq Rules regarding the Qualification, Listing and Delisting of Companies (the “Nasdaq Listing Rules”). On March 31, 2023, the Company filed Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed until after the completion of the accounting and disclosures related to the Company’s acquisition of a majority interest in NanoSynex, Ltd included in its Annual Report.

 

Although the Company dedicated significant resources to the completion of its audited consolidated financial statements and related disclosures for inclusion in the Form 10-K, the Company was unable to complete and file the Form 10-K prior to April 17, 2023, the extension period provided by the Form 12b-25. The delay was due primarily to the Company’s acquisition of a majority interest in NanoSynex, Ltd. and additional information and investigation needed in relation to the Company’s financial statements to complete the audit. Under Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company generally has 60 calendar days from the date of the deficiency letter to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq Listing Rules.

 

This notification has no immediate effect on the listing of the Company’s common stock on the Nasdaq. However, if the Company fails to timely regain compliance with the Nasdaq Listing Rule, the Company’s common stock will be subject to delisting from Nasdaq.

 

The Company is working diligently and expects to file the Form 10-K within the 60-day period, which ends on June 20, 2023, which would eliminate the need for the Company to submit a formal plan to regain compliance.

 

 

 

 

About Qualigen Therapeutics, Inc.

 

Qualigen Therapeutics, Inc. is a diversified life sciences company focused on developing treatments for adult and pediatric cancer, while also commercializing diagnostics. Our investigational QN-302 compound is a small molecule selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells; such binding could, by stabilizing the G4s against “unwinding,” help inhibit cancer cell proliferation. The investigational compounds within Qualigen’s family of RAS oncogene protein-protein interaction inhibitor small molecules are believed to inhibit or block the binding of mutated RAS genes’ proteins to their effector proteins, thereby leaving the proteins from the mutated RAS unable to cause further harm. In theory, such mechanism of action may be effective in the treatment of about one quarter of all cancers, including certain forms of pancreatic, colorectal, and lung cancers. Our investigational QN-247 compound inhibits nucleolin, a key multi-functional regulatory protein that is overexpressed in cancer cells; QN-247 may thereby be able to inhibit the cells’ proliferation. QN-247 has shown promise in preclinical studies for the treatment of acute myeloid leukemia (AML). In addition to its oncology drug pipeline, Qualigen has an established diagnostics business which manufactures and distributes proprietary and highly accurate rapid blood testing systems to physician offices and small hospitals for the management of prostate cancer and other diseases and health conditions.

 

For more information about Qualigen Therapeutics, Inc., please visit www.qualigeninc.com.

 

Forward-Looking Statements

 

This news release contains forward-looking statements by Qualigen that involve risks and uncertainties and reflect the Company’s judgment as of the date of this release. These statements include those related to the Company’s expected timing for filing the Form 10-K and its ability to regain compliance with Nasdaq’s continued listing requirements. These statements are subject to risks and uncertainties, and actual results may differ materially from these statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking statements beyond the date of this release, except as required by law. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

 

Contact:

 

Jules Abraham

JQA Partners, Inc.

917-885-7378

jabraham@jqapartners.com

 

Source: Qualigen Therapeutics, Inc.

 

 

 GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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qlgn-20230421.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 qlgn-20230421_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 qlgn-20230421_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Apr. 21, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 21, 2023
Entity File Number 001-37428
Entity Registrant Name Qualigen Therapeutics, Inc.
Entity Central Index Key 0001460702
Entity Tax Identification Number 26-3474527
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2042 Corte Del Nogal
Entity Address, City or Town Carlsbad
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92011
City Area Code (760)
Local Phone Number 918-9165
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $.001 per share
Trading Symbol QLGN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001460702 2023-04-21 2023-04-21 iso4217:USD shares iso4217:USD shares 0001460702 false 8-K 2023-04-21 Qualigen Therapeutics, Inc. DE 001-37428 26-3474527 2042 Corte Del Nogal Carlsbad CA 92011 (760) 918-9165 false false false false Common Stock, par value $.001 per share QLGN NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://0001460702/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex99-1.htm qlgn-20230421.xsd qlgn-20230421_lab.xml qlgn-20230421_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "qlgn-20230421_lab.xml" ] }, "presentationLink": { "local": [ "qlgn-20230421_pre.xml" ] }, "schema": { "local": [ "qlgn-20230421.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "QLGN", "nsuri": "http://0001460702/20230421", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-04-21to2023-04-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://0001460702/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-04-21to2023-04-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://0001460702/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001493152-23-013314-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-013314-xbrl.zip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end